HLK Biotech Holding Group, Inc. (AMHD)
HLK Biotech Holding Group, Inc. operates primarily through its various subsidiaries, focusing on the production and distribution of biodiesel. In addition to its energy sector activities, the company also engages in the acquisition of real estate assets. The firm was formerly recognized as Amelot Holdings, Inc., but it officially rebranded to HLK Biotech Holding Group, Inc. in February 2018. The company's principal office is located in Norfolk, Virginia.
Sector: Drug Manufacturers - Specialty & Generic
Industry: Drug Manufacturers - Specialty & Generic
HLK Biotech Holding Group, Inc.
- Not computed: no float on record for this company.
- Not published: no settled short interest on record.
- Not stated: no basis-consistent volume to divide the settled position by.
The cost to borrow AMHD shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.
- No fails on record for 16–31 Oct 2026.
No price or settlement history available to chart.
FINRA publishes no off-exchange short volume for this symbol.
FINRA's weekly alternative trading system (dark pool) volume for AMHD: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.